Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study

Headache

Volumn 37, Issue 10, 1997, Pages 640-645

  Klassen, Arthur ^a,d   Elkind, Arthur ^b   Asgharnejad, Mahnaz ^c   Webster, Chris ^c   Laurenza, Antonio ^c  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^b Elkind Headache Center   (United States)

^c GLAXOSMITHKLINE   (United States)

^d UMCH ^*  (United States)

Author keywords

5 HT1; Headache; Migraine; Naratriptan

Indexed keywords

NARATRIPTAN; PLACEBO; SEROTONIN AGONIST;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MIGRAINE; NAUSEA; ORAL DRUG ADMINISTRATION; PHOTOPHOBIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; TREATMENT PLANNING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INDOLES; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PIPERIDINES; SEROTONIN AGONISTS; TRYPTAMINES;

EID: 0031436667     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1997.3710640.x     Document Type: Article

References (9)

1. Connor HE, Feniuk W, Beattie DT, et al. Naratriptan: biological profile in animal models relevant to migraine. Cephalalgia. In press.
2. Fuseau E, Baille P, Kempsford RD. Absolute bioavailability of oral naratriptan. Neurology. In press. Abstract.
3. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
4. Cutler N, Mushet GR, Davis R, Clements B, Whitcher L. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths. Neurology. 1995;45(suppl 7):S5-S9.
5. Sargent J, Kirchner JR, Davis R, Kirkhart B. Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study. Neurology. 1995;45(suppl 7):S10-S14.
6. Nappi G, Sicuteri F, Byrne M, Roncolato M, Zerbini O. Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol. 1994;241:138-144.
7. Geraud GEA. Evaluation of the long-term safety and efficacy of 311C90 in the treatment of migraine. Eur Neurol. 1996;36(suppl 2):24-27.
8. Visser WH, Terwindt GM, Reines SA, Jiang K, Lines CR, Ferrari MD. Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Arch Neurol. 1996;53:1132-1137.
9. Cady RK, Rubino J, Crummett D, Littlejohn TW III. Oral sumatriptan in the treatment of recurrent headache. Arch Fam Med. 1994;3:766-772.